Enanta Pharmaceuticals' P/S ratio remains low despite recent...
Enanta Pharmaceuticals' P/S ratio remains low despite recent share price jump, likely due to weak revenue forecast. Market sentiment doesn't anticipate a strong share price rise soon.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002432de6a84ad8c.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment